Interleukin-6 Antagonists in Critically-ill Covid-19 Patients
NCT05218369
·
clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Critical Illness
Interventions
DRUG:
IL6 Antagonist
Sponsor
University of Pecs